Clinical trials: Bronchial Hyperresponsiveness
- Condition Bronchial Hyperresponsiveness
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Asthma
Treatment Of Symptomatic Asthma In Children
This study is being conducted to investigate whether in childhood salmeterol/ fluticasone propionate 50/100 bd delivered via the Diskus® inhaler and fluticasone propionate 200 mcg bd delivered via the Diskus® inhaler are non…
- Trial name
- NCT00197106
- Testing
- Salmeterol/ fluticasone propionate Diskus® inhaler 50/100 mcg, fluticasone propionate 2 x 100 mcg
- Where
- 18 sites in Netherlands
- Volunteers
- 176 people
- Sponsor
- GlaxoSmithKline
Asthma
Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug Administration Approved Asthma Medications
This study was designed to evaluate if, in children with asthma, a stepwise treatment (five levels varying from once daily fluticasone propionate 100mcg until twice daily a fixed combination of salmeterol and fluticasone…
- Trial name
- NCT00158834
- Testing
- Salmeterol/Fluticasone propionate combination product, Fluticasone propionate
- Where
- 16 sites in Netherlands
- Volunteers
- 200 people
- Sponsor
- GlaxoSmithKline
Asthma
Ability of Aridol to Detect Bronchial Hyperresponsiveness in Suspected Asthmatics
This is a Phase 3 study to determine the sensitivity and specificity of the Aridol bronchial challenge test to detect bronchial hyperresponsiveness in patients with suspected asthma.
- Trial name
- NCT00252291
- Testing
- Aridol, Methacholine, Exercise challenge
- Where
- United States
- Volunteers
- 240 people
- Sponsor
- Syntara
Asthma
GSK BHR Study (Sont - Second Study)
The purpose of this study was to determine whether asthma control and reduced bronchial responsiveness could be achieved and maintained at a lower dose of inhaled corticosteroids with ADVAIR DISKUS BID or FP BID in adult and…
- Trial name
- NCT01324362
- Testing
- FP 100mcg, FP 250mcg, FP 500mcg
- Where
- 57 sites in United States, Brazil and 2 more
- Volunteers
- 446 people
- Sponsor
- GlaxoSmithKline
Asthma
GSK BHR Study (Sont)
The purpose of this study was to determine whether asthma control and reduced bronchial hyperresponsiveness could be achieved and maintained at a lower dose of inhaled corticosteroids with ADVAIR DISKUS twice-daily or FP…
- Trial name
- NCT00920543
- Testing
- FP 100mcg, FP 500mcg, FP 250mcg
- Where
- 58 sites in United States, Brazil and 2 more
- Volunteers
- 464 people
- Sponsor
- GlaxoSmithKline
Asthma
A Long Term Prospective Follow Up Study For The CATO Study (SAS30018/SER9702)
The CATO population is a very well documented population during two years. During this study patients were treated according to the CATO algorithm, after that patient were treated according to the Dutch national (GINA derived)…
- Trial name
- NCT00441675
- Testing
- Symptom Score, Symptom Score and PD20
- Where
- 15 sites in Netherlands
- Volunteers
- 137 people
- Sponsor
- GlaxoSmithKline